Changes in Laboratory Variables in Rheumatoid Arthritis Patients During a Trial of Fasting and One-year Vegetarian Diet

References

• Kjeldsen-Kragh I, Haugen M, Borchgrevink C F, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991; 338: 899–902
   PubMed Web of Science ®Google Scholar
• Makinde V A, Senaldi G, Jawad A SM, Berry H, Vergani D. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis 1989; 48: 302–6
   PubMed Web of Science ®Google Scholar
• Garred P, Mollnes T E, Harboe M, Berntzen H B, Munthe E. C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis. Scand J Rheumatol 1991; 20: 183–9
   PubMed Web of Science ®Google Scholar
• Oleesky D A, Daniels R H, Williams B D, Amos N, Morgan BP. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions. Clin Exp Immunol 1991; 84: 250–5
   PubMed Web of Science ®Google Scholar
• Corvetta A, Pomponio G, Rinaldi N, Luchetti M M, Di Loreto C, Stramazzotti D. Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoar-thritis and acute joint trauma. Clin Exp Rheumatol 1992; 10: 433–8
   PubMed Web of Science ®Google Scholar
• Withrington R H, Teitsson I, Valdimarsson H, Seifert MH. Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 1984; 43: 679–85
   PubMed Web of Science ®Google Scholar
• Highton J, Hessian P A, Small B, Palmer DG. An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 1985; 12: 854–8
   PubMed Web of Science ®Google Scholar
• Robbins D L, Feigal DW, Jr., Leek JC. Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis. J Rheumatol 1986; 13: 259–62
   PubMed Web of Science ®Google Scholar
• Quinn C, Mulpeter K, Casey E B, Feighery CF. Changes in levels of IgM RF and α 2 PAG correlate with increased disease activity in rheumatoid arthritis during the puerperium. Scand J Rheumatol 1993; 22: 273–9
   PubMed Web of Science ®Google Scholar
• Østensen M, Lundgren R, Husby G, Rekvig OP. Studies on humoral immunity in pregnancy: immunoglobulins, alloantibo-dies and autoantibodies in healthy pregnant women and in pregnant women with rheumatoid disease. J Lab Clin Med 1983; 11: 143–7
   Google Scholar
• Gottlieb N L, Kiem I M, Penneys N S, Schultz DR. The influence of chrysotherapy on serum protein and immunoglobulin levels, rheumatoid factor, and antiepithelial antibody titers. J Lab Clin Med 1975; 86: 962–72
   PubMed Web of Science ®Google Scholar
• Highton J, Panayi G S, Shepherd P, Faith A, Griffin J, Gibson T. Fall in immune complex levels during gold treatment of rheumatoid arthritis. Ann Rheum Dis 1981; 40: 575–9
   PubMed Web of Science ®Google Scholar
• Lessard J, Nunnery E, Cecere F, McDuffy S, Pope RM. Relationship between the articular manifestations of rheumatoid arthritis and circulating immune complexes detected by three methods and specific classes of rheumatoid factors. J Rheumato1 1983; 10: 411–7
   PubMed Web of Science ®Google Scholar
• Manicourt D-H, Triki R, Fukuda K, Devogelaer J-P, de Deuxchaisnes C N, Thonar EJ-MA. Levels of circulating tumor necrosis factor a and interleukin-6 in patients with rheumatoid arthritis. Arthritis Rheum 1993; 36: 490–9
   PubMed Web of Science ®Google Scholar
• Altomonte L, Zoli A, Mirone L, Scolieri P, Magaró M. Serum levels of interleukin-1b, tumour necrosis factor-a and interleu-kin-2 in rheumatoid arthritis. Correlation with disease activity. Clin Rheumatol 1992; 11: 202–5
   PubMedGoogle Scholar
• Beckham J C, Caldwell D S, Peterson B L, et al. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-a, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. J Clin Immunol 1992; 12: 353–61
   PubMed Web of Science ®Google Scholar
• Berntzen H B, Munthe E, Fagerhol MK. The major leukocyte protein L1 as an indicator of inflammatory joint disease. Scand J Rheumatol 1988; 251–6, Suppl 76
   Google Scholar
• Berntzen H B, Munthe E, Fagerhol MK. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989; 16: 1416–20
   PubMed Web of Science ®Google Scholar
• Brun J G, Haga H J, Boe E, et al. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol 1992; 19: 859–62
   PubMed Web of Science ®Google Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar RA. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Kjeldsen-Kragh J, Haugen M, Førre Ø, Laache H, Malt UF. Vegetarian diet for patients with rheumatoid arthritis: can the clinical effects be explained by the psychological characteristics of the patients?. Br J Rheumatol 1994; 33: 569–75
   PubMedGoogle Scholar
• Fries J F, Spitz P, Kraines R G, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45
   PubMed Web of Science ®Google Scholar
• Tugwell P, Boers M. for the OMERACT Committee. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. J Rheumatol 1993; 20: 555–6
   PubMed Web of Science ®Google Scholar
• Steinbrocker O, Traeger C H, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659–62
   PubMed Web of Science ®Google Scholar
• Roseth A G, Fagerhol M K, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793–8
   PubMed Web of Science ®Google Scholar
• Schultz-Ellison G, Charland C, Driscoll J, Thayer W. A rapid method for immune complex detection: PEG-insolubilisation combined with nephelometry. J Immunol Methods 1979; 31: 31–40
   PubMed Web of Science ®Google Scholar
• Kleveland G, Egeland T, Lea T. Quantitation of rheumatoid factors (RF) of IgM, IgA and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgG-RE Scand J Rheumatol 1988; 15–24, Suppl 75
   Google Scholar
• Garred P, Mollnes T, Lea T. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988; 27: 329–35
   PubMed Web of Science ®Google Scholar
• Mollnes T E, Lea T, Froland S S, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22: 197–202
   PubMed Web of Science ®Google Scholar
• Gould AL. A new approach to the analysis of clinical drug trials with withdrawals. Biometrics 1980; 36: 721–7
   PubMed Web of Science ®Google Scholar
• Borg G, Allander E, Lund B, et al. Auronofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind, placebo controlled study. J Rheumatol 1988; 15: 1747–54
   PubMed Web of Science ®Google Scholar
• Pincus T. The case for early intervention in rheumatoid arthritis. J Autoimmun 1992; 5: 206–26, Suppl A
   Web of Science ®Google Scholar
• Palmblad J, Cantell K, Holm G, Norberg R, Wanders H, Sunblad L. Acute energy deprivation in man: effect on serum immunoglobulins antibody response, complement factors 3 and 4, acute phase reactants and interferon-producing capacity of blood lymphocytes. Clin Exp Immunol 1977; 30: 50–5
   PubMed Web of Science ®Google Scholar
• Espersen G T, Grunnet N, Lervang H H, et al. Decreased in-terleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol 1992; 11: 393–5
   PubMed Web of Science ®Google Scholar
• Barrera P, Boerbooms A MT, Janssen E M, et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Arthritis Rheum 1993; 36: 1070–9
   PubMed Web of Science ®Google Scholar
• Lindahl O, Lindwall L, Spangberg A, Stenram A, Ökerman PA. A vegan regimen with reduced medication in the treatment of hypertension. Br J Nutr 1984; 52: 11–20
   PubMed Web of Science ®Google Scholar
• Walford R L, Hams S B, Gunion MW. The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc Natl Acad Sci USA 1992; 89: 11533–7
   PubMed Web of Science ®Google Scholar
• Haugen M, Kjeldsen-Kragh J, Skakkebaek N, et al. The influence of fast and vegetarian diet on parameters of nutritional status in patients with rheumatoid arthritis. Clin Rheumatol 1993; 12: 62–9
   PubMed Web of Science ®Google Scholar
• Kjeldsen-Kragh J, Haugen M, Borchgrevink C F, Forre Ø. Vegetarian diet for patients with rheumatoid arthritis - Status: two years after introduction of the diet. Clin Rheumatol 1994; 13: 475–82
   PubMed Web of Science ®Google Scholar